‘Thanks to the efforts of health workers. , and the widespread availability of treatment, malaria still only kills a small number of people in Thailand each year,’ according to the BBC. ‘The focus now is on trying to monitor and consist of artemisinin drug resistance into a few hotspots, prolonging the drug's effective lifespan globally until alternative treatments are available,’ the news provider writes, adding, ‘Africa's expectations of maintaining its progress rests firmly on South East Asia's efforts.’ Fatoumata Nafo-Traore, executive director of Roll Back Malaria and the previous wellness minister of Mali, stated if drug-resistant malaria reached Africa, it could be a ‘substantial crisis’ because there is not an alternative medication to the usually highly effective artemisinin-based drugs, relating to BBC .Their patent portfolios are kept by the Wisconsin Alumni Research Foundation , UW-Madison’s tech transfer vehicle, and iPS Academia Japan, which manages the intellectual residence related to methods of creating iPS cells from Kyoto University, respectively. Access to both these patent portfolios, furthermore to CDI’s previously disclosed IP, further establishes the company as the first choice in iPSC technology. ICell Cardiomyocytes are utilized by the pharmaceutical industry to test new drug candidates, flagging ineffective or potentially toxic drug substances early in the medication discovery process. The company plans to release several extra cell types, including liver, neural, and blood vessel cells, within the next 12 to 1.